Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent endometrial cancer: a retrospective study.

F H van Wijk1, F J Huikeshoven, L Abdulkadir

  • 1Department of Obstetrics and Gynecological Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 8, 2006
PubMed
Summary

Regular follow-up programs are valuable for detecting recurrent endometrial cancer within three years. Screen-detected recurrences show better survival rates, highlighting the importance of vigilant monitoring post-treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cells.

Acta physiologica (Oxford, England)·2016
Same author

Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.

European journal of gynaecological oncology·2016
Same author

Melanoma risk after ovarian stimulation for in vitro fertilization.

Human reproduction (Oxford, England)·2015
Same author

Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment data.

European journal of cancer (Oxford, England : 1990)·2014
Same author

Progesterone-induced cyclin G1 inhibits the proliferation of endometrial epithelial cell and its possible molecular mechanism.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Human reproduction (Oxford, England)·2013

Area of Science:

  • Gynecologic Oncology
  • Clinical Oncology
  • Cancer Recurrence Monitoring

Background:

  • Endometrial cancer recurrence poses a significant challenge in patient management.
  • Effective follow-up strategies are crucial for early detection and improved outcomes.

Purpose of the Study:

  • To evaluate the utility of follow-up programs in detecting endometrial cancer recurrence.
  • To analyze the impact of detection methods on patient survival.

Main Methods:

  • Retrospective analysis of 64 patients with recurrent endometrial cancer over 20 years.
  • Evaluation of clinical data, histopathological features, and mode of recurrence detection.
  • Survival analysis using Kaplan-Meier curves.

Main Results:

Related Experiment Videos

  • Most local (95%) and distant (67%) recurrences were detected within three years.
  • Screen-detected recurrences were associated with a higher 5-year survival rate (62%) compared to interval screening or chance findings (47%).
  • Overall 5-year survival rate was 53%.

Conclusions:

  • A follow-up program in the first three years post-treatment is beneficial for endometrial cancer recurrence detection.
  • Current follow-up protocols appear suitable for patients with low-risk primary disease.